NEVVI Medicare utilization intelligence
or

← back

Provider profile

COHEN, MICHAEL M.D.

Ophthalmology · NPI 1699038935 · PLYMOUTH MEETING, PA

2
Groups
21
Codes · 2024
32,684
Disclosed services

COHEN, MICHAEL is a Ophthalmology in PLYMOUTH MEETING, PA, a member of 2 medical groups, who billed 21 distinct codes to Medicare Part B in 2024.

Groups: ASSOCIATED RETINAL SURGEONS, PA (CHERRY HILL, NJ) · RETINOVITREOUS ASSOCIATES LTD (PHILADELPHIA, PA) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

32,684
disclosed services
21
codes billed to Medicare Part B
Prior year · CY2023 24,916 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J2777 Injection, faricimab-svoa, 0.1 mg
Q5128 Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg
92134 Imaging of retina
J0178 Injection, aflibercept, 1 mg
67028 Injection of drug into eye
92012 Established patient problem focused exam of visual system
92014 Established patient complete exam of visual system
J0177 Injection, aflibercept hd, 1 mg
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3590 Unclassified biologics
92004 New patient complete exam of visual system
92201 Extended exam of the back part of the eye with retinal drawing
J7999 Compounded drug, not otherwise classified
76512 2d ultrasound scan of eye tissue and structures
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
67036 Removal of eye fluid (vitreous) between lens and retina
67042 Removal of membrane of retina with removal of internal limiting membrane of retina
67113 Complex repair of detached retina and drainage of eye fluid between lens and retina
67145 Photocoagulation treatment to prevent detachment of retina
92250 Photography of the retina

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.